Cargando…
HOXC6 impacts epithelial-mesenchymal transition and the immune microenvironment through gene transcription in gliomas
BACKGROUND: Gliomas are the most common primary malignant tumours of the central nervous system (CNS). To improve the prognosis of glioma, it is necessary to identify molecular markers that may be useful for glioma therapy. HOXC6, an important transcription factor, is involved in multiple cancers. H...
Autores principales: | Huang, Hui, Huo, Zhengyuan, Jiao, Jiantong, Ji, Wei, Huang, Jin, Bian, Zheng, Xu, Bin, Shao, Junfei, Sun, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052479/ https://www.ncbi.nlm.nih.gov/pubmed/35488304 http://dx.doi.org/10.1186/s12935-022-02589-9 |
Ejemplares similares
-
The expression and prognostic value of the epidermal growth factor receptor family in glioma
por: Xu, Bin, et al.
Publicado: (2021) -
Noncoding RNAs involved in the STAT3 pathway in glioma
por: Bian, Zheng, et al.
Publicado: (2021) -
HOXC8: a predictive glioma biomarker that induces epithelia-mesenchymal transition
por: Liang, Tingyu, et al.
Publicado: (2018) -
HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition
por: Li, Pin-Dong, et al.
Publicado: (2018) -
HOXC6 Regulates the Epithelial-Mesenchymal Transition through the TGF-β/Smad Signaling Pathway and Predicts a Poor Prognosis in Glioblastoma
por: Eryi, Sun, et al.
Publicado: (2022)